Alnylam Pharmaceuticals
ALNY
#429
Rank
ยฃ40.70 B
Marketcap
ยฃ308.12
Share price
2.02%
Change (1 day)
54.77%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company